Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital [NA]

View source ↗

Summary

This entry reports a clinical trial at Quinze-Vingts Hospital evaluating a post-diagnostic announcement protocol for retinitis pigmentosa; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts | Conditions: Retinitis Pigmentosa (RP) | NA | Status: RECRUITING